AI fertility start-up Alife to pilot tools with leading clinic chain US Fertility
The collaboration aims to improve laboratory operations through innovative AI technology
A leading chain of US fertility clinics will pilot AI in fertility tools from San Francisco-based tech company Alife Health.
US Fertility is the nation’s largest partnership of physician-owned fertility practices with more than 200 physicians operating in 100 locations. It will pilot Alife’s ‘Embryo Assist’ software to help labs to precisely and consistently grade and catalogue embryos - and ultimately decide how each embryo might be used. Patients too can be given more advanced insight into the embryo labs as they move through the IVF cycle.
‘Embryo Assist’ integrates with lab microscopes and means embryologists can easily capture images of embryos and data to support lab quality-control measures. For every embryo the tool generates activity reports and audit trails, while a cloud-based platform provides real-time lab updates so that embryologists have immediate access to the latest data for informed decision-making.
Kate Devine, MD, Medical Director and Chief Research Officer of US Fertility said:
"Our partnership with Alife marks a significant advancement in our laboratory capabilities."
"By integrating AI and data-driven tools into our IVF processes, we aim to continue delivering exceptional care to our patients while providing them with further insight into the precision and consistency of our laboratories."
US Fertility performs over 50,000 IVF retrieval cycles annually between its 200 physicians, and has helped more than 225,000 individuals and couples on their journey to build their families through assisted reproductive technology.
Alife Health was founded in 2020 and is backed by VC investors including Lux Capital, Maveron and Union Square Ventures. It raised a Series A of $22m in 2022.
Melissa Teran, CEO of Alife Health, said:
"Alife is honored to partner with US Fertility to bring our cutting-edge AI solutions into their laboratories."
"Through this pilot collaboration, we will equip embryologists with a powerful tool that streamlines operations and enhances clinical efficiency. Together, we are advancing IVF through innovation."
.